Phthalates Are Out, Accurate Detection Using LC-MS/MS Technology Is In

Sep 1, 2017 | Blogs, Food / Beverage | 0 comments

Whether you like it or not, the plastics industry is a growing market. According to an Allied Market Research report, it was valued at $15,179 million in 2015 and is projected to reach $18,538 million by 2022, growing at a CAGR of 2.9% from 2016 to 20221. Additionally, according to the report, in 2015, phthalates type held two-thirds of the global market in 2015. An important statistic since the use of various phthalates is restricted in many countries because of health concerns2.

Phthalates Facts
Even so, phthalates are widely used industrial chemicals with an estimated annual production of over 8,000,000 tons. Phthalates are added to plastics to increases flexibility, transparency, and longevity. By weight, they contribute 10-60% of plastic products. Phthalates are used in a variety of products, including building materials (caulk, paint, adhesives), household products (vinyl upholstery, shower curtains, food containers and wrappers), and cosmetics3.

More importantly, “Bio-based plasticizers, such as epoxides and sebacates, are expected to grow at the highest CAGR throughout the analysis period, due to their remarkable properties such as non-toxic nature, high efficiency, improved heat stability, lower volatility, and others. These are employed in automotive, adhesive & sealants, paints and coatings, and other end uses.4

Tech Note Details
Knowing the global population is pushing back on the use of phthalates due to health concerns, the following tech note, Increasing Selectivity and Confidence in Detection when Analyzing Phthalates by LC-MS/MS, portrays a fast and sensitive LC-MS/MS method for the analysis of 22 phthalates in food. Phthalates can leach into food, especially hot or fatty ingredients, during manufacturing cross-contamination, or via food packaging5.

Therefore, fast and sensitive LC-MS/MS method was developed for the detection of 22 phthalates in food and beverage samples. After reading the tech note, you will learn MRM transitions, MRM3, EPI spectra, and SelexION Technology.

Alternatives for phthalates do exist, and according to the U.S. Environmental and Protective Agency (EPA) report, a European ban on some of these chemicals has led to the development of plasticizers based on isosorbide esters6. In addition to certain government bans, companies like Target want phthalates gone from baby, beauty, and cleaning products by 20207. Apple uses safer thermoplastic elastomers8 while Microsoft, Kaiser-Permanente, hospitals, and certain city operations use alternatives.Learn More About Food and Beverage Testing >

  1. http://www.digitaljournal.com/pr/3385574
  2. DIRECTIVE 2005/84/EC on ‘phthalates in toys and childcare articles’ 3 EPA ‘Phthalates Action Plan Summary’ 2010
  3. R.A. Rudel and L.A. Perovich: Atmospheric Environment 43 (2009) 170-181
  4. http://www.digitaljournal.com/pr/3385574
  5. https://www.niehs.nih.gov/research/supported/assets/docs/j_q/phthalates_the_everywhere_chemical_handout_508.pdf
  6. https://www.epa.gov/sites/production/files/2015-09/documents/phthalates_actionplan_revised_2012-03-14.pdf p. 3
  7. https://www.bizjournals.com/twincities/news/2017/01/26/target-wants-pfcs-phthalates-off-its-shelves.html
  8. https://www.apple.com/environment/safer-materials/

 

PFAS testing: 2024 in review and what to expect for 2025

For as long as PFAS persist in the environment, there is no doubt they will persist in our conversations as environmental scientists. Globally, PFAS contamination has been detected in water supplies, soil and even in the blood of people and wildlife. Different countries are at various stages of addressing PFAS contamination and many governments have set regulatory limits and are working on assessing the extent of contamination, cleaning up affected sites and researching safer alternatives.

Inside the box: Acoustic ejection mass spectrometry for drug discovery

On average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.

Unveiling the power of ZT Scan DIA: Insights from Ludwig Sinn’s presentation at World HUPO Congress 2024

In a recent presentation at the World HUPO Congress 2024, Ludwig Sinn from the Ralser lab shared exciting advancements in proteomics research, focusing on the innovative ZT Scan DIA acquisition modes developed in collaboration with SCIEX. Let us explore the key highlights and benefits of this innovative technology.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial